These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34968554)

  • 1. Antidepressant-like actions of the mGlu2/3 receptor antagonist TP0178894 in the chronic social defeat stress model: Comparison with escitalopram.
    Dong C; Tian Z; Fujita Y; Fujita A; Hino N; Iijima M; Hashimoto K
    Pharmacol Biochem Behav; 2022 Jan; 212():173316. PubMed ID: 34968554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine.
    Dong C; Zhang JC; Yao W; Ren Q; Ma M; Yang C; Chaki S; Hashimoto K
    Int J Neuropsychopharmacol; 2017 Mar; 20(3):228-236. PubMed ID: 27765808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression.
    Yang B; Zhang JC; Han M; Yao W; Yang C; Ren Q; Ma M; Chen QX; Hashimoto K
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3647-57. PubMed ID: 27488193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of rapid antidepressant effects of Kir4.1 channel inhibitors in a chronic social defeat stress model: Comparison with (R)-ketamine.
    Xiong Z; Zhang K; Ishima T; Ren Q; Ma M; Pu Y; Chang L; Chen J; Hashimoto K
    Pharmacol Biochem Behav; 2019 Jan; 176():57-62. PubMed ID: 30502360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression.
    Zhang JC; Yao W; Dong C; Yang C; Ren Q; Ma M; Han M; Hashimoto K
    Psychopharmacology (Berl); 2015 Dec; 232(23):4325-35. PubMed ID: 26337614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of rapid and long-lasting antidepressant effects of negative modulators of α5-containing GABA
    Xiong Z; Zhang K; Ishima T; Ren Q; Chang L; Chen J; Hashimoto K
    Pharmacol Biochem Behav; 2018 Dec; 175():139-145. PubMed ID: 30359627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits.
    Witkin JM; Monn JA; Schoepp DD; Li X; Overshiner C; Mitchell SN; Carter G; Johnson B; Rasmussen K; Rorick-Kehn LM
    J Pharmacol Exp Ther; 2016 Jul; 358(1):71-82. PubMed ID: 27189960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal administration of transforming growth factor-β1 elicits rapid-acting antidepressant-like effects in a chronic social defeat stress model: A role of TrkB signaling.
    Wei Y; Chang L; Hashimoto K
    Eur Neuropsychopharmacol; 2021 Sep; 50():55-63. PubMed ID: 33971385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats.
    Koike H; Chaki S
    Behav Brain Res; 2014 Sep; 271():111-5. PubMed ID: 24909673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The group II mGlu receptor antagonist LY341495 induces a rapid antidepressant-like effect and enhances the effect of ketamine in the chronic unpredictable mild stress model of depression in C57BL/6J mice.
    Pałucha-Poniewiera A; Podkowa K; Rafało-Ulińska A
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jul; 109():110239. PubMed ID: 33400944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test.
    Fukumoto K; Iijima M; Chaki S
    Psychopharmacology (Berl); 2014 Jun; 231(11):2291-8. PubMed ID: 24402133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential roles of neuropeptide VGF regulated TrkB/mTOR/BICC1 signaling and phosphorylation of AMPA receptor subunit GluA1 in the rapid antidepressant-like actions of ketamine in mice.
    Shen M; Lv D; Liu X; Li S; Chen Y; Zhang Y; Wang Z; Wang C
    Brain Res Bull; 2018 Oct; 143():58-65. PubMed ID: 30316917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Hydroxytryptamine-Independent Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model.
    Zhang K; Dong C; Fujita Y; Fujita A; Hashimoto K
    Int J Neuropsychopharmacol; 2018 Feb; 21(2):157-163. PubMed ID: 29155989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors.
    Nasca C; Xenos D; Barone Y; Caruso A; Scaccianoce S; Matrisciano F; Battaglia G; Mathé AA; Pittaluga A; Lionetto L; Simmaco M; Nicoletti F
    Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4804-9. PubMed ID: 23382250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.
    Koike H; Fukumoto K; Iijima M; Chaki S
    Behav Brain Res; 2013 Feb; 238():48-52. PubMed ID: 23098797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of AMPA receptors in the antidepressant-like effects of dextromethorphan in mice.
    Nguyen L; Matsumoto RR
    Behav Brain Res; 2015 Dec; 295():26-34. PubMed ID: 25804358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model.
    Yang B; Ren Q; Ma M; Chen QX; Hashimoto K
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27608811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (
    Zanos P; Highland JN; Stewart BW; Georgiou P; Jenne CE; Lovett J; Morris PJ; Thomas CJ; Moaddel R; Zarate CA; Gould TD
    Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6441-6450. PubMed ID: 30867285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of dopamine D
    Chang L; Zhang K; Pu Y; Qu Y; Wang SM; Xiong Z; Shirayama Y; Hashimoto K
    Eur Arch Psychiatry Clin Neurosci; 2020 Mar; 270(2):271-275. PubMed ID: 30927075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice.
    Ago Y; Yano K; Araki R; Hiramatsu N; Kita Y; Kawasaki T; Onoe H; Chaki S; Nakazato A; Hashimoto H; Baba A; Takuma K; Matsuda T
    Neuropharmacology; 2013 Feb; 65():29-38. PubMed ID: 23022081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.